Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™House Resolution 1039 from the 118th Congress recognizes the importance of Charcot-Marie-Tooth disease, a neurological disorder, and emphasizes the need for increased funding for the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH). The resolution aims to raise awareness and support for research funding to address this disease. The bill was referred to the Subcommittee on Health but ultimately failed or expired without further legislative action. No full text or detailed summary is available.
H.Res.1039 highlights the significance of Charcot-Marie-Tooth disease and calls for robust funding of NINDS at NIH, but it did not advance beyond subcommittee referral and expired.
- The resolution formally recognizes Charcot-Marie-Tooth disease as a significant neurological disorder.
- It calls for increased and robust funding for the National Institute of Neurological Disorders and Stroke at NIH.
- The bill was referred to the House Subcommittee on Health but did not progress further and expired.
['Individuals affected by Charcot-Marie-Tooth disease', 'National Institute of Neurological Disorders and Stroke (NINDS)', 'Researchers and medical professionals focused on neurological disorders', 'Potentially the broader neurological disease research community']
['The resolution does not specify funding amounts or mechanisms, which may limit its direct impact on budget allocations.', 'As a House resolution, it does not have the force of law to mandate funding increases or program changes.', 'Lack of detailed legislative text or implementation guidance may hinder measurable outcomes.', 'No oversight or enforcement provisions are included.']
This resolution was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It reflects congressional interest in neurological diseases and NIH funding priorities but did not advance to a vote or become law. The resolution's failure or expiration indicates it did not gain sufficient legislative traction during the session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased awareness of Charcot-Marie-Tooth disease among lawmakers and the public could lead to future legislative or funding initiatives.', 'Potential encouragement for NIH and NINDS to prioritize research on this disease within existing budgets.', 'Advocacy groups may use the resolution as a platform to support further policy or funding efforts.']
The resolution lacks detailed legislative text and funding provisions, limiting transparency on how increased funding would be implemented or monitored. Its non-binding nature means it does not directly affect NIH appropriations or program priorities. Tracking subsequent related legislation or appropriations requests would be necessary to assess actual impact on funding and research for Charcot-Marie-Tooth disease.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.